Cullinan Oncology Inc.

NASDAQ: CGEM · Real-Time Price · USD
7.67
0.09 (1.19%)
At close: Aug 15, 2025, 3:59 PM
7.66
-0.07%
After-hours: Aug 15, 2025, 04:10 PM EDT

Cullinan Oncology Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
72.82M 76.66M 83M 102.08M 115.02M 74.23M 98.43M 64.85M 512.12M 122.13M 550.12M 242.66M 353.56M 76.12M 430.86M 88.11M 123.67M 293.54M
Short-Term Investments
192.66M 227.17M 315.97M 475.99M 547.47M 358.78M 368.63M 401.58M 349.96M 268.57M 311.14M 333.29M 257.43M 238.74M 230.69M 232.94M 213.03M 147.34M
Long-Term Investments
242.3M 259.39M 204.44M 57.98M n/a n/a n/a 13.54M 18.63M 110.44M 80.88M 29.41M 43.18M 94.18M 140.4M 124.33M 119.64M 32.11M
Other Long-Term Assets
367K 366K 366K 460K 460K 460K 459K 459K -13.42M 459K 459K 460K 100K 147K 147K 147K 147K 147K
Receivables
n/a n/a 3M n/a n/a n/a 5.4M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a n/a n/a -5.4M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Assets
10.43M 13.95M 12.69M 13.96M 15.3M 12.71M n/a 10.28M 6.44M 8.33M 7.18M 6.12M 11.85M n/a 6.1M 7.79M 7.76M 6.42M
Total Current Assets
275.91M 317.77M 414.67M 592.04M 677.8M 445.72M 480.19M 476.71M 512.12M 399.03M 474.47M 582.08M 622.84M 322.31M 296.56M 328.84M 344.47M 447.29M
Property-Plant & Equipment
1.75M 2.16M 2.35M 2.78M 2.96M 3.25M 3.53M 3.99M 4.66M 5.06M 5.3M 5.29M 1.13M 1.26M 77K 89K 102K 115K
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
244.42M 261.91M 207.16M 61.22M 3.42M 3.71M 4.91M 18M 9.87M 115.96M 86.64M 35.16M 44.41M 115.15M 140.62M 124.57M 119.89M 32.37M
Total Assets
520.33M 579.68M 621.82M 653.25M 681.22M 449.43M 485.1M 494.71M 521.98M 514.99M 561.12M 617.24M 667.25M 437.46M 437.19M 453.4M 464.35M 479.67M
Account Payables
2.46M 3.4M 1.68M 2.12M 1.55M 3.71M 2.49M 951K 2.49M 2.03M 2.66M 1.52M 3.1M 6.31M 3.17M 2.02M 1.51M 3.88M
Deferred Revenue
n/a n/a n/a n/a n/a n/a n/a n/a 12.62M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Short-Term Debt
1.39M n/a n/a n/a n/a 1.33M 1.44M 1.92M 1.89M 1.85M 178K 696K 533K 804K n/a n/a n/a n/a
Other Current Liabilities
19.39M 2.79M 1.44M 14.96M 16.6M 190K 15.78M 1.58M 1.03M 9.32M 6.24M 21.81M 8.93M n/a 973K 97K 5K 5.45M
Total Current Liabilities
28.06M 27.35M 30.65M 24.2M 23.48M 21.93M 28.14M 23.44M 19.68M 26.17M 22.5M 27.12M 62.03M 17.26M 11.75M 7.86M 5.74M 9.89M
Long-Term Debt
125K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 65K 67K 70K 73K
Total Long-Term Liabilities
125K 493K 849K 1.19M 1.52M 1.84M 3.06M 2.45M 2.73M 3.17M 3.59M 3.99M 596K 736K 65K 67K 70K 73K
Total Liabilities
28.18M 27.84M 31.5M 25.39M 25M 23.77M 31.2M 25.89M 22.41M 29.34M 26.09M 31.11M 62.63M 17.99M 11.81M 7.93M 5.81M 9.97M
Total Debt
1.52M 1.84M 2.15M 2.45M 2.73M 3.17M 3.59M 5.92M 6.27M 6.57M 5.19M 4.69M 1.13M 2.06M n/a n/a n/a n/a
Common Stock
6K 6K 6K 6K 6K 4K 4K 4K 4K 4K 5K 5K 5K 4K 4K 4K 4K 4K
Retained Earnings
-486.8M -416.74M -368.24M -320.59M -280.03M -238M -200.86M -177.05M -137.87M -105.66M -47.7M -20.91M 3.89M -171.01M -158.91M -126.39M -109.05M -93.41M
Comprehensive Income
607K 505K -133K 970K -476K -331K -129K -1.05M -1.63M -1.24M -2.6M -3.93M -3.63M -3.13M -838K -58K -115K -60K
Shareholders Equity
492.15M 551.84M 590.33M 627.86M 656.22M 425.67M 453.7M 468.82M 499.57M 485.65M 535.03M 586.13M 604.54M 418.7M 422.58M 443.39M 455.55M 466.9M
Total Investments
434.96M 486.56M 520.41M 533.97M 547.47M 358.78M 368.63M 415.13M 368.6M 379.01M 392.02M 362.71M 300.61M 332.91M 461.38M 357.27M 332.67M 179.45M